CHINA PHARMA HOLDINGS, INC. (NYSEMKT:CPHI) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition. |
On March 31, 2017, the registrant issued a press release
announcing (i) certain financial results for the fiscal year
ended December 31, 2016; and (ii) a conference call to be held by
the registrant on Friday, March 31, 2017 at 8:30 a.m. Eastern
Time to discuss the results of operations for the fiscal year
ended December 31, 2016. A copy of the press release is attached
hereto as Exhibit 99.1.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
The following is filed as an exhibit to this report:
| Exhibit No. |
Description |
|
|
99.1 |
Press Release, dated March 31, 2017 |
About CHINA PHARMA HOLDINGS, INC. (NYSEMKT:CPHI)
China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People’s Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others. CHINA PHARMA HOLDINGS, INC. (NYSEMKT:CPHI) Recent Trading Information
CHINA PHARMA HOLDINGS, INC. (NYSEMKT:CPHI) closed its last trading session down -0.009 at 0.252 with 66,949 shares trading hands.